Usefulness of 18F-FDG PET–Directed Skeletal Biopsy for Metastatic Neoplasm
Authors:
- Cherryl A. SadowCSCherryl A. Sadow
- Carl S. WinalskiCWCarl S. Winalski
- Philipp K. LangPLPhilipp K. Lang
- John E. ReadyJRJohn E. Ready
- John A. CarrinoJCJohn A. Carrino
- 31 August 2006
- journal article
- research article
- Published by Elsevier in Academic Radiology
- Vol. 13 (8) , 1011-1015
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imagingSeminars in Nuclear Medicine, 2004
- Clinical Role of FDG PET in Evaluation of Cancer PatientsRadioGraphics, 2003
- Comparison of Bone and 2-Deoxy-2-[18F]Fluoro-D-Glucose Positron Emission Tomography in the Evaluation of Bony Metastases in Lung CancerMolecular Imaging and Biology, 2003
- The role of positron emission tomography in skeletal diseaseSeminars in Nuclear Medicine, 2001
- Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1998
- Detection of bony metastases of androgen-independent prostate cancer by PET-FDGNuclear Medicine and Biology, 1996
- Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.Radiology, 1996